Loading
PB
PCI Biotech Holding ASA Stock: price and insider trades · Norway
PCI Biotech Holding ASA: what insiders have been doing
PCI Biotech Holding ASA, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to Oslo Børs. No insider at PCI Biotech Holding ASA has published a filing in the past twelve months. The most recent one dates from 10 January 2025.
For comparison within the same sector, see the insider buying recorded at Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. Every figure here comes from the filings published by Oslo Børs and describes the past, not future prices; it is not investment advice.
Insider Decl.
7
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
5 ops. · all time
Who traded when
BuySalePCI Biotech1 sale
Financial data
as of FY 2024FY ended December 2024 · cache
NOK 0.07
Analyst consensus
Income statement
Net income-NOK 16.4M0.0% margin
Valuation
P/Book0.2x
Beta0.79
Balance sheet & cash
Market capNOK 2.6M
Total debtNOK 336k
Free Cash Flow-NOK 13.8M
Debt / Equity2%
Profitability & ownership
ROE-92.5%
ROA-48.3%
% insiders23.0%
% institutions5.7%
Last declaration on 10 January 2025
Declarations7 total
OptionXOSLOSLO:636288
OptionXOSLOSLO:626809
OptionXOSLOSLO:598689
OptionXOSLOSLO:576772
OptionXOSLOSLO:541730
7 of 7 declarations
About PCI Biotech Holding ASA
PCI Biotech Holding ASA is a Norwegian biopharmaceutical company focused on developing innovative treatments for cancer. It utilizes phototherapy technology to enhance the efficacy of anticancer drugs.
